https://www.moneycontrol.com/news/business/ipo/mankind-pharma-ipo-shares-trade-with-single-digit-premium-in-grey-market-10439601.html
Mankind Pharma is focused largely on the domestic market, which contributed to 97.60 percent to its revenue from operations for FY22.
Create an account or login to join the discussion